Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Aditya H Gaur"'
Autor:
Diego R Hijano, James M Hoffman, Li Tang, Stacey L Schultz-Cherry, Paul G Thomas, Hana Hakim, Richard J Webby, Randall T Hayden, Aditya H Gaur, St. Jude COVID-19 Employee Screening Program Team
Publikováno v:
PLoS ONE, Vol 17, Iss 5, p e0268237 (2022)
COVID-19 remains a challenge worldwide, and testing of asymptomatic individuals remains critical to pandemic control measures. Starting March 2020, a total of 7497 hospital employees were tested at least weekly for SARS CoV-2; the cumulative incidenc
Externí odkaz:
https://doaj.org/article/ba231879958941cba82380b1c9bfecd9
Autor:
Baligh R Yehia, Alisa J Stephens-Shields, John A Fleishman, Stephen A Berry, Allison L Agwu, Joshua P Metlay, Richard D Moore, W Christopher Mathews, Ank Nijhawan, Richard Rutstein, Aditya H Gaur, Kelly A Gebo, HIV Research Network
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129376 (2015)
The HIV care continuum (diagnosis, linkage to care, retention in care, receipt of antiretroviral therapy (ART), viral suppression) has been used to identify opportunities for improving the delivery of HIV care. Continuum steps are typically calculate
Externí odkaz:
https://doaj.org/article/d9894cb3a97b49578d37930f9c427d25
Autor:
Diego R. Hijano, Sandra R. Dennis, James M. Hoffman, Li Tang, Randall T. Hayden, St. Jude COVID-19 Case Investigation and Contact Tracing Team, Aditya H. Gaur, Hana Hakim
Publikováno v:
Frontiers in Public Health, Vol 11 (2024)
BackgroundCase investigations and contact tracing are essential disease control measures used by health departments. Early in the pandemic, they were seen as a key strategy to stop COVID-19 spread. The CDC urged rapid action to scale up and train a l
Externí odkaz:
https://doaj.org/article/f805fc8ca08547e58c2a4e9802719000
Autor:
Jesse Smith, Yilun Sun, Diego R. Hijano, James M. Hoffman, Hana Hakim, Richard J. Webby, Randall T Hayden, Aditya H. Gaur, Gregory T. Armstrong, Motomi Mori, Li Tang
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background COVID-19 has caused over 305 million infections and nearly 5.5 million deaths globally. With complete eradication unlikely, organizations will need to evaluate their risk and the benefits of mitigation strategies, including the ef
Externí odkaz:
https://doaj.org/article/f9a7b6d639f34e6a9da91ca033830176
Autor:
Aditya H. Gaur, John C. Panetta, Amber M. Smith, Ronald H. Dallas, Burgess B. Freeman, III, Tracy B. Stewart, Li Tang, Elizabeth John, Kristen C. Branum, Nehali D. Patel, Shelley Ost, Ryan N. Heine, Julie L. Richardson, Jared T. Hammill, Lidiya Bebrevska, Fabian Gusovsky, Noritsugu Maki, Toshiharu Yanagi, Patricia M. Flynn, James S. McCarthy, Stephan Chalon, R. Kiplin Guy
Publikováno v:
EBioMedicine, Vol 80, Iss , Pp 104065- (2022)
Summary: Background: SJ733, a newly developed inhibitor of P. falciparum ATP4, has a favorable safety profile and rapid antiparasitic effect but insufficient duration to deliver a single-dose cure of malaria. We investigated the safety, tolerability,
Externí odkaz:
https://doaj.org/article/d8cb0aafdaa14141ac20c3e2254e7c3d
Autor:
Jane C. Lindsey, Michael Hudgens, Aditya H. Gaur, Keith J. Horvath, Ronald Dallas, Barbara Heckman, Megan Mueller Johnson, K. Rivet Amico
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 92:231-241
Autor:
Diego R. Hijano, James M. Hoffman, Richard J. Webby, Li Tang, Hana Hakim, Randall T. Hayden, Aditya H. Gaur
Publikováno v:
Influenza and Other Respiratory Viruses. 16:851-853
The objective of this study is to assess the utility of a nucleic acid amplification test-based approach to shorten isolation of healthcare workers (HCWs) with COVID-19 in the setting of the highly transmissible omicron variant.Between December 24, 2
Autor:
Danielle Porter, Heather Maxwell, Eva Natukunda, Pope Kosalaraksa, Hal Martin, Mun Sang Yue, Carina A. Rodriguez, Sophia Majeed, Kulkanya Chokephaibulkit, Hiba Graham, Diana M. Brainard, Cheryl A. Pikora, Pamela Wong, Elizabeth Helström, Mark F. Cotton, Afaaf Liberty, Aditya H. Gaur, Eric McGrath
Publikováno v:
The Lancet Child & Adolescent Health. 5:642-651
Bictegravir is a potent integrase strand-transfer inhibitor (INSTI) with a high genetic barrier to resistance. Bictegravir, coformulated with emtricitabine and tenofovir alafenamide, is recommended by key European and US HIV treatment guidelines as t
Autor:
Diego R, Hijano, Zhengming, Gu, Jessica, Brazelton, Haiqing, Zhu, Sri, Suganda, Heather L, Glasgow, Himani, Darji, Li, Tang, Thomas P, Fabrizio, Kim J, Allison, E Kaitlynn, Allen, Aditya H, Gaur, Joshua, Wolf, Paul G, Thomas, Richard J, Webby, Elaine I, Tuomanen
Publikováno v:
Open Forum Infectious Diseases. 9
Although numerous studies have evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using cycle threshold (Ct) values as a surrogate of viral ribonucleic acid (RNA) load, few studies have used standardized, quantitative me
Autor:
Betty M Rupp, Aditya H. Gaur, Barbara Heckman, Rachel West Goolsby, Michael G. Hudgens, Melissa Polier, Ini Ubong, Keith J. Horvath, Megan Mueller Johnson, Teresa Filipowicz, K. Rivet Amico, Ronald H. Dallas, Jessica Crawford, Jane C. Lindsey
Publikováno v:
AIDS Patient Care STDS
A sizable portion of youth (ages 13–24) living with HIV in the United States have unsuppressed viral load. The AIDS Interventions (ATN) 152 study [evaluating the Triggered Escalating Real-Time Adherence (TERA) intervention] baseline data were exami